共 50 条
κ-opioids induce a reversible inhibition of CFU-GM from CD133+ cord blood cells
被引:1
|作者:
Dimitriou, H.
Bakogeorgou, E.
Kampa, M.
Notas, G.
Stiakaki, E.
Kouroumalis, E.
Kalmanti, M.
Castanas, E.
机构:
[1] Univ Crete, Sch Med, Dept Pediat Hematol Oncol, GR-71003 Iraklion, Crete, Greece
[2] Univ Crete, Sch Med, Lab Expt Endocrinol, Iraklion, Crete, Greece
[3] Univ Crete, Sch Med, Lab Gastroenterol, Iraklion, Crete, Greece
来源:
关键词:
CD133+;
CFU-GM;
cord blood;
hemopoietic progenitors;
opioids;
D O I:
10.1080/14653240600847183
中图分类号:
Q813 [细胞工程];
学科分类号:
摘要:
Background Opioid agonists have been shown to exert an inhibitory action on a number of malignant and non-malignant cell types. However, there are no reports dealing with their effect on hemopoietic progenitors. Based upon our previous experience of opioid agonists we examined whether opioids could interfere with the growth of CFU-GM from CD133(+) cord blood cells. Methods Cord blood samples were subjected to CD133(+) column selection, with subsequent exposure to opioid agonists and antagonists or both, in semi-solid cultures for CFU-GM growth. Colonies of day 7 of culture were replated in fresh medium in the absence of opioids. The colonies were evaluated at 7 and 14 days of culture. RT-PCR was performed for the detection of opioid and somatostatin receptors. Apoptosis tests and immunophenotypic evaluations were employed in liquid cultures in conditions identical to those of the semi-solid ones. Results and discussion Our results suggest that opioids can induce a significant inhibition of CFU-GM growth, which is reversible and not mediated through opioid or somatostatin receptors, while apoptosis is not implicated. Whether this finding could be used for clinical intervention remains to be examined.
引用
收藏
页码:367 / 374
页数:8
相关论文